Neuphoria Therapeutics Inc.
NASDAQ: NEUP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Spyridon Papapetropoulos
- Employees
- 8
- Headquarters
- Burlington, United States
- IPO year
- 2021
- Market cap
- $24.3M
- Website
- http://www.neuphoriatx.com
Loading NEUP…
Loading profile data…Frequently asked questions about NEUP
What does Neuphoria Therapeutics Inc. (NEUP) do?
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporat...
Where does NEUP trade?
Neuphoria Therapeutics Inc. (NEUP) trades on the NASDAQ Global Market.
What sector is NEUP in?
Neuphoria Therapeutics Inc. (NEUP) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Neuphoria Therapeutics Inc.?
Spyridon Papapetropoulos is the chief executive officer of Neuphoria Therapeutics Inc. (NEUP).
Where is Neuphoria Therapeutics Inc. headquartered?
Neuphoria Therapeutics Inc. is headquartered in United States.
Does NEUP pay a dividend?
Neuphoria Therapeutics Inc. (NEUP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NEUP go public?
Neuphoria Therapeutics Inc. (NEUP) completed its initial public offering in 2021.